Board of Directors

Yariv Alroy


Yariv served in shl Telemedicine’s Co-CEO from 2000 until January 15,2016. He previously served as managing director of SHL Telemedicine International Ltd from 1997 to 2000 and Chief Operating Officer of the Company from 1993 to 1997. He also previously served as a Member of the Board of Directors of the Company between 2001 and 2006, and between 2010 and 2014. Before joining the Company, Yariv worked for a leading Israeli law firm from 1989 to 1993,with my last position being senior partner. Since 2016 He as been an investor and a businessman and serves as a Board Member of Duke Robotics Inc., a private reporting US corporation.He hold an LL.B from Tel Aviv University

Erez Alroy

Mr. Alroy served in various executive positions in SHL Telemedicine since its inception, as its Co-CEO from 2000 to January 2015 and as a director from 2008 to 2014.He is currently active in various investments and is a board member in Merhavia Holdings Ltd (TASE:MRHL) and is the Chairman of Migvan Engineering and Technology Ltd.Mr. Alroy holds an MBA from the Hebrew University in Jerusalem. Nationality: Israeli.

Prof. Amir Lerman

Prof. Lerman joined the Board of Directors of SHL as a non-executive Director in 2016. Prof. Lerman is the Vice-Chair, Cardiovascular Department and the Director of the Cardiovascular Research Center at the Mayo Clinic in Rochester (USA) since 2010. He is also the Program Director for vascular and valve, Center for Regenerative Medicine at the Mayo Clinic, since 2012. In addition, Prof. Lerman serves as the Director of the Mayo-Israeli startup company initiative as well as a faculty member at the Mirage Institute: US-Israel innovation bridge business leadership program, since 2009, in addition to various other positions held at the Mayo Clinic. Prof. Lerman also holds an appointment as Professor of Medicine at the Mayo Medical School since 2001. Prof. Lerman graduated from the Technion school of Medicine in Haifa Israel in 1985 and completed his training in internal medicine, cardiovascular diseases and invasive cardiology at the Mayo Clinic in 1994. Prof. Lerman published more than 500 manuscripts, book chapters and reviews; the NIH, AHA, and several foundations support his research. Nationality: American/ Israeli.

Yehoshua (Shuky) Abramovich

Mr. Abramovich joined the Board of Directors of SHL as a nonexecutive Director/ Independent (external) Director in June 2017. Mr. Abramovich has held key positions in the Israeli capital market for over 25 years. He serves as the chairman of the board of Somoto limited, chairman of Atrade, member of the board of directors and chairman of the investment committee of I.D.I Insurance company and as a director in few other high-tech, real estate and energy companies. Mr. Abramovich was the CEO of Clal Finance during several years, one of Israel’s largest financial institutions who provided a broad array of financial services ranging from portfolio management to brokerage and underwriting services. Clal Finance owned and managed mutual funds, an in-house hedge fund, and offered individually tailored structured products to clients. Prior to that, he served in various positions in Clal group, including Deputy CEO of Clal Insurance Enterprises Holdings. He served on the board of directors of the Tel-Aviv Stock Exchange until Sept 2009, and he is a member of the board of trustees of the Academic Track of the College of Management (COM). He has a B.A. in Economics & business. Nationality: Israeli.

Erez Nachtomy


Mr. Erez Nachtomy serves as a member of the Board since December 2018 and as Acting CEO of the company as of May 2020. From 1989 until 2001 Erez practiced law at a leading Israeli law firm – Weksler, Bregman & Co., becoming a partner in the firm in 1994 and later on promoted to a senior partner. In March 2001, He joined the executive team of SHL Telemedicine Ltd., as Vice President, and from January 2005 to December 2016 He served as Executive Vice President of the Company. Since 2017 he is an investor and a businessman specializing in strategic planning, M&A transactions, and capital raising and business development. He serves as a Board Member of Duke Robotics, Inc., a private reporting US corporation. Erez hold an LL.B. from Tel Aviv University, Israel and he is a member of the Israeli Bar.
Nationality: Israeli.

Dvora Kimhi

Ms. Dvorah Kimhi joined the Board of Directors of SHL as a non-executive Director / Independent (external) Director in December 2018. She also served as a nonexecutive Independent (external) Director in the Company from 2010 to 2014 and as a nonexecutive director from 2001 to 2007. Since 2002 and as of the date hereof, Ms. Kimhi serves as Vice President for regulatory and legal affairs with Channel 10, one of the two existing Israeli commercial television channels. Prior to this Ms. Kimhi served as Chief Legal Advisor to Ananey Communications Ltd., Noga Communications and the Israeli Educational Television. Ms. Kimhi also serves on the board of directors of Kol Hayyam Hadrom Ltd., an Israel radio station. Ms. Kimhi is a member of the Israeli Bar, holds an LL.B. from Tel Aviv University and has specialized in contract law and communication regulation. Nationality: Israeli.

David Salton

Mr. Salton joined the Board of Directors avid Salton as independent, non-executive director effective as of 31 May 2021. David currently holds the position of Chief Executive Officer of Virility Medical, a startup company developing consumer medical devices. Prior to that, he served as CEO of DCL Technologies Ltd., an investment company, and Deputy General Manager of Leumi Partners, a leading Israeli Investment Bank. David Salton also served as CEO of several private biotech and healthcare companies, and as board member of several publicly traded companies. He currently is an independent director of InterCure Ltd. (TASE, TSX: INCR) and ARAN Ltd. (TASE: ARAN). David Salton holds a B.Sc., Economics & Management degree from Technion – Israel Institute of Technology, Faculty of Industrial Engineering & Management. Nationality: Israeli.